Packing batteries with more punch
Indian researchers are working on cells that can store more energy, last longer
India has refused to agree to permanent tariff concessions on health and farm products at the World Trade Organisation as an answer to Covid-19 trade disruptions proposed by some member countries, mostly rich. Further, it has argued that the proposal may be a ploy to gain additional market access.
At a recent meeting of the WTO’s General Council to exchange views on the economic and trade impact of the pandemic, New Delhi argued that developing countries needed to continue protecting their nascent industries. “...the narrative-push by some WTO members to seek permanent tariff liberalisation on a range of products in response to a temporary crisis appears to be a thinly veiled bid to use the crisis as an opportunity to gain market access for their exporters,” said India’s statement at the meeting.
Australia, New Zealand, Singapore, Canada, Chile and Brunei had come up with a joint statement a few weeks earlier against the imposition of export controls, or tariff and non-tariff barriers. They also opposed the removing of any existing trade restrictive measures on essential goods, especially medical supplies, amid the battle against Covid-19.
“Developing countries seeking to shore up manufacturing capacity in medical products will require tariff protection for their nascent domestic industry. Further, job losses in many service sectors have to be compensated elsewhere. Therefore, India, like many other developing countries, cannot agree to permanent tariff concessions, and a dilution of the tariff bindings that we have paid for in the Uruguay Round,” said India’s statement.
Members are free to reduce customs duties on imports of certain medical or agricultural products to zero if it serves their health and food security objectives, but it has to be on a voluntary basis, it added.
Uneven impact
In formulating a response to the Covid-19 disruptions, it is critical to bear in mind that the impact of the pandemic will be felt unevenly, though widely, the statement pointed out. “The strain on economic, food and livelihood security will disproportionately impact developing countries and LDCs (least developed countries) with large populations and limited resources. Therefore, they need special treatment,” India said in the statement.
However, India also acknowledges the importance of coordinating the global response to avoid disruptions in the flow of vital medical supplies, food and other goods and services across borders, and has been playing a proactive role in ensuring the availability of vital drugs such as hydroxychloroquine and paracetamol across the globe, it added.
Please Email the Editor